- Home
- AVTX vs NECB Comparison
AVTX vs NECB Comparison
Compare AVTX & NECB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVTX
- NECB
- Stock Information
- Founded
- AVTX 2011
- NECB 1934
- Country
- AVTX United States
- NECB United States
- Employees
- AVTX N/A
- NECB N/A
- Industry
- AVTX Biotechnology: Pharmaceutical Preparations
- NECB Savings Institutions
- Sector
- AVTX Health Care
- NECB Finance
- Exchange
- AVTX Nasdaq
- NECB Nasdaq
- Market Cap
- AVTX 248.3M
- NECB 282.4M
- IPO Year
- AVTX 2015
- NECB N/A
- Fundamental
- Price
- AVTX $17.99
- NECB $20.24
- Analyst Decision
- AVTX Strong Buy
- NECB
- Analyst Count
- AVTX 9
- NECB 0
- Target Price
- AVTX $30.14
- NECB N/A
- AVG Volume (30 Days)
- AVTX 417.9K
- NECB 51.3K
- Earning Date
- AVTX 11-07-2025
- NECB 10-23-2025
- Dividend Yield
- AVTX N/A
- NECB 3.82%
- EPS Growth
- AVTX N/A
- NECB N/A
- EPS
- AVTX N/A
- NECB 3.21
- Revenue
- AVTX $441,000.00
- NECB $102,569,000.00
- Revenue This Year
- AVTX N/A
- NECB $1.90
- Revenue Next Year
- AVTX N/A
- NECB $6.93
- P/E Ratio
- AVTX N/A
- NECB $6.30
- Revenue Growth
- AVTX N/A
- NECB N/A
- 52 Week Low
- AVTX $3.39
- NECB $19.41
- 52 Week High
- AVTX $19.41
- NECB $31.72
- Technical
- Relative Strength Index (RSI)
- AVTX 69.56
- NECB 46.69
- Support Level
- AVTX $15.58
- NECB $20.00
- Resistance Level
- AVTX $19.20
- NECB $20.63
- Average True Range (ATR)
- AVTX 1.66
- NECB 0.62
- MACD
- AVTX 0.26
- NECB 0.08
- Stochastic Oscillator
- AVTX 77.22
- NECB 47.43
About AVTX Avalo Therapeutics Inc.
Avalo Therapeutics Inc is a clinical-stage biotechnology company focused on the treatment of immune dysregulation. The company's asset is AVTX-009, an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalo's pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein).
About NECB NorthEast Community Bancorp Inc.
NorthEast Community Bancorp Inc operates as a community-oriented financial institution. It is principally engaged in the business of attracting deposits and investing those funds into mortgage and commercial loans. It conducts activities throughout the Northeastern United States including New York, Massachusetts, New Jersey, and Connecticut. The company offers a comprehensive line of banking products and services, including mobile banking as well as commercial real estate loans, commercial construction financing, lines of credit, and term loans. It also offers investment advisory and financial planning services.